Literature DB >> 15905101

Cholesterol and phospholipid efflux from cultured cells.

Emma I Waddington1, Emmanuel Boadu, Gordon A Francis.   

Abstract

The removal of phospholipids and cholesterol from tissues is the major mechanism mediating the initial assembly of high density lipoproteins (HDL), as well as being the main reason HDL are thought to protect against atherosclerosis. Investigations of the mechanisms of HDL assembly and testing of novel HDL-raising agents typically involve assays to determine phospholipid and/or cholesterol removal or "efflux" from cultured cells. The purpose of this chapter is to describe experimental protocols that can be used in the determination of cholesterol and phospholipid efflux from cultured cells by HDL apolipoproteins for the formation of new HDL particles, and the testing of novel HDL-raising therapies in vitro. A protocol is also provided for determining the size and nature of HDL particles formed in cell-conditioned medium using two-dimensional gel electrophoresis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905101     DOI: 10.1016/j.ymeth.2004.12.002

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  4 in total

1.  Lysosomal acid lipase deficiency impairs regulation of ABCA1 gene and formation of high density lipoproteins in cholesteryl ester storage disease.

Authors:  Kristin L Bowden; Nicolas J Bilbey; Leanne M Bilawchuk; Emmanuel Boadu; Rohini Sidhu; Daniel S Ory; Hong Du; Teddy Chan; Gordon A Francis
Journal:  J Biol Chem       Date:  2011-07-10       Impact factor: 5.157

2.  Tailoring of biomimetic high-density lipoprotein nanostructures changes cholesterol binding and efflux.

Authors:  Andrea J Luthi; Heng Zhang; Dongwoo Kim; David A Giljohann; Chad A Mirkin; C Shad Thaxton
Journal:  ACS Nano       Date:  2011-12-01       Impact factor: 15.881

Review 3.  HDL and Reverse Cholesterol Transport.

Authors:  Mireille Ouimet; Tessa J Barrett; Edward A Fisher
Journal:  Circ Res       Date:  2019-05-10       Impact factor: 17.367

4.  Enhanced hepatic apoA-I secretion and peripheral efflux of cholesterol and phospholipid in CD36 null mice.

Authors:  Pin Yue; Zhouji Chen; Fatiha Nassir; Carlos Bernal-Mizrachi; Brian Finck; Salman Azhar; Nada A Abumrad
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.